Publication number: 20040127576
Abstract: The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant inventive are ligands for estrogen receptors and as such may be useful for treatment or prevention of a variety of conditions related to estrogen functioning including bone loss, bone fractures, osteoporosis, cartilage degeneration, endometriosis, uterine fibroid disease, hot flashes, increased levels of LDL cholesterol, cardiovascular disease, impairment of cognitive functioning, cerebral degenerative disorders, restinosis, gynecomastia, autoimmune disease, vascular smooth muscle cell proliferation, obesity, incontinence, and cancer of the lung, colon, breast, uterus, and prrostate.
Type:
Application
Filed:
January 20, 2004
Publication date:
July 1, 2004
Inventors:
Konrad Koehler, Cecilia Hensen, Marita Nilsson, Mikael Gillner, Ye Liu, Andrei Sanin, Robert R. Wilkening, Ronald W. Ratcliffe, David Wensbo